Philips joins European Federation of Cancer Imaging to advance Precision Medicine in Oncology


Philips has announced its active membership in the new consortium of the European Federation for Cancer Imaging (EUCAIM), a key project within the European Cancer Imaging Initiative officially launched by the European Commission at an event held in Brussels (Belgium) two weeks before World Cancer Day 2023.

The European Cancer Imaging Initiative will work to create a digital infrastructure connecting cancer imaging databases and resources across the European Union, while ensuring adherence to strict ethics, trust, security and data protection standards.

Thus, it wants to respond to the need of researchers to access cancer data worldwide and with the necessary quality to develop new solutions that help detect, diagnose and treat cancer, particularly all those based on artificial intelligence (AI). .

Within this Initiative, the EUCAIM project will focus on designing and deploying a federated cancer imaging diagnostic data infrastructure, and the resulting atlas will be made available to the second key project of this initiative: the Intelligence Experimentation and Testing Center Artificial Intelligence for Health (TEF-Health), which will allow subject matter experts and other partners to test AI-based solutions for cancer treatment using real data. The proposed infrastructure will also provide a platform for European citizens to be able to donate their data to cancer research.

“We at Philips very much welcome this initiative as it offers access to oncology data and also an excellent opportunity to engage and collaborate with this community. This will help develop AI-powered solutions derived from this data and validate them with clinical partners and partners such as Hospital La Fe in Valencia or the Charité in Berlin.This initiative has an immediate application in innovations in cancer, since these are based on longitudinal patient data, as well as on a wide set of them, to guarantee solutions of robust AI being adopted in clinical practice,” said Philips Vice President of Data, AI and Digital Innovation Tina Manoharan.

One of the key objectives of the European Plan ‘Beating Cancer’ is to ensure that 90 percent of the EU population who meet the requirements to undergo a screening for breast, cervical or colorectal cancer can receive it in the year 2025, which will result in a considerable increase in the volume of images from screening, in greater precision diagnosis and personalized treatment of detected cases.

AI is widely seen as a powerful tool that could help radiologists cope with the increased workload. Combining artificial intelligence with deep clinical insight, Philips is already creating solutions that integrate into clinical workflows, speed them up and provide clinicians with greater clarity at every stage of the cancer care journey.

For example, Philips MRCAT Brain software uses trained AI models to capture the information needed to accurately and efficiently generate each patient’s radiotherapy plan in a single, rapid MRI scan, without the need for a CT scanner, which it consumes more time and resources, and the subsequent joint registration of CT-MR images.

Philips is currently collaborating with the Leiden University Medical Center in the Netherlands, which benefited from a €2 million grant from the Dutch Research Council (NWO), to develop new innovative AI solutions to accelerate and improve MR examinations further with the aim of reducing examination times to less than five minutes and reconstructing detailed images despite the movement of the patient or internal organs.

“By automating and speeding up routine imaging tasks, our AI-powered solutions aim to simplify workflows and logistics, leaving clinicians more time to focus on their patients’ needs. At the same time, our imaging tools AI-powered image reconstruction, quantitative analysis, and data integration enable oncologists to make better-informed decisions in diagnosis, therapy planning, treatment, and follow-up to provide their patients with the precise, personalized cancer care they deserve “, said Reema Poddar, executive vice president of Philips Diagnostic and Clinical Informatics.

Intelligent imaging solutions and clinical informatics solutions from Philips combine data from radiology, pathology, genomics, and electronic health record systems to provide a comprehensive, multiple view of each patient’s cancer status, through plug-ins such as the multimodal tumor tracking, spectral tumor tracking, and CT virtual colonoscopy to aid decision-making.

In addition, the solution offers an additional layer of information access and management that includes clinical pathways, genomic computing, clinical reports, and comparison with Dana-Farber Cancer Institute clinical trials.

During the European Congress of Radiology (March 1-5, Vienna, Austria), Philips will present its latest intelligent AI-based technologies that help drive meaningful insights and improve clinical confidence and patient outcomes.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button